“…Varicose veins (VV) represent the most frequent chronic venous disease in the general population, reaching a 21% pooled prevalence [ 4 ], and although innovative treatments are continuously proposed, ineluctably, a 30% or higher mid/long-term recurrence rate is documented by most publications [ 1 , 2 , 4 ]. The most recent endovenous procedures, based for example on laser, radiofrequency, (catheter-)foam sclerotherapy, glue and mechanochemical ablation, are showing promising results, but a higher degree of evidence is still required as to their long-term efficacy [ 1 , 2 , 4 , 5 ]. Surgery is still considered a feasible and useful therapeutic procedure for VV, but only if practised in a mini-invasive and tailored modality in order to improve its efficacy, safety and cost-effectiveness [ 1 , 4 , 6 ].…”